Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants.
Saved in:
| Title: | Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants. |
|---|---|
| Authors: | de Andrade KC; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: kelvin.deandrade@nih.gov., Strande NT; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA., Kim J; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Haley JS; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA., Hatton JN; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Frone MN; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Khincha PP; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Thone GM; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA., Mirshahi UL; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA., Schneider C; Division of Hematology/Oncology, Department of Medicine and Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Desai H; Division of Hematology/Oncology, Department of Medicine and Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Dove JT; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA., Smelser DT; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA., Levine AJ; Simons Center for Systems Biology, Institute for Advanced Study, Princeton, NJ, USA., Maxwell KN; Division of Hematology/Oncology, Department of Medicine and Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Stewart DR; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Carey DJ; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA., Savage SA; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. |
| Corporate Authors: | Penn Medicine BioBank, Regeneron Genetics Center |
| Source: | HGG advances [HGG Adv] 2024 Jan 11; Vol. 5 (1), pp. 100242. Date of Electronic Publication: 2023 Sep 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101772885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-2477 (Electronic) Linking ISSN: 26662477 NLM ISO Abbreviation: HGG Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37777824 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22de+Andrade+KC%22">de Andrade KC</searchLink>; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: kelvin.deandrade@nih.gov.<br /><searchLink fieldCode="AU" term="%22Strande+NT%22">Strande NT</searchLink>; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Kim+J%22">Kim J</searchLink>; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Haley+JS%22">Haley JS</searchLink>; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Hatton+JN%22">Hatton JN</searchLink>; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Frone+MN%22">Frone MN</searchLink>; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Khincha+PP%22">Khincha PP</searchLink>; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Thone+GM%22">Thone GM</searchLink>; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Mirshahi+UL%22">Mirshahi UL</searchLink>; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Schneider+C%22">Schneider C</searchLink>; Division of Hematology/Oncology, Department of Medicine and Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Desai+H%22">Desai H</searchLink>; Division of Hematology/Oncology, Department of Medicine and Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Dove+JT%22">Dove JT</searchLink>; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Smelser+DT%22">Smelser DT</searchLink>; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Levine+AJ%22">Levine AJ</searchLink>; Simons Center for Systems Biology, Institute for Advanced Study, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Maxwell+KN%22">Maxwell KN</searchLink>; Division of Hematology/Oncology, Department of Medicine and Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Stewart+DR%22">Stewart DR</searchLink>; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Carey+DJ%22">Carey DJ</searchLink>; Department of Genomic Health, Geisinger Clinic, Geisinger, Danville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Savage+SA%22">Savage SA</searchLink>; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Penn+Medicine+BioBank%22">Penn Medicine BioBank</searchLink><br /><searchLink fieldCode="CA" term="%22Regeneron+Genetics+Center%22">Regeneron Genetics Center</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101772885%22">HGG advances</searchLink> [HGG Adv] 2024 Jan 11; Vol. 5 (1), pp. 100242. <i>Date of Electronic Publication: </i>2023 Sep 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101772885 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-2477 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226662477%22">26662477 </searchLink><i>NLM ISO Abbreviation: </i>HGG Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37777824 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.xhgg.2023.100242 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100242 Titles: – TitleFull: Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: de Andrade KC – PersonEntity: Name: NameFull: Strande NT – PersonEntity: Name: NameFull: Kim J – PersonEntity: Name: NameFull: Haley JS – PersonEntity: Name: NameFull: Hatton JN – PersonEntity: Name: NameFull: Frone MN – PersonEntity: Name: NameFull: Khincha PP – PersonEntity: Name: NameFull: Thone GM – PersonEntity: Name: NameFull: Mirshahi UL – PersonEntity: Name: NameFull: Schneider C – PersonEntity: Name: NameFull: Desai H – PersonEntity: Name: NameFull: Dove JT – PersonEntity: Name: NameFull: Smelser DT – PersonEntity: Name: NameFull: Levine AJ – PersonEntity: Name: NameFull: Maxwell KN – PersonEntity: Name: NameFull: Stewart DR – PersonEntity: Name: NameFull: Carey DJ – PersonEntity: Name: NameFull: Savage SA IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 01 Text: 2024 Jan 11 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2666-2477 Numbering: – Type: volume Value: 5 – Type: issue Value: 1 Titles: – TitleFull: HGG advances Type: main |
| ResultId | 1 |